Dishman Pharma’s arm completes US FDA PAI for a new hi potency drug

03 Oct 2011 Evaluate

Dishman Pharmaceuticals and Chemicals’ Switzerland based wholly owned subsidiary -- Carbogen Amcis AG -- has successfully completed US Food and Drug Administration (US FDA)  Pre Approval Inspection (PAI) for a new hi potency drug for a US multinational.

Carbogen Amcis is a leading service provider, offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industry, at all stages of drug development.

Dishman Pharmaceuticals and Chemicals (DPCL) is engaged in manufacturing of Bulk API, Intermediates, Specialties and Quats. The company has started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds in 1989.

Peers
Company Name CMP
Sun Pharma Inds. 1523.75
Dr. Reddys Lab 6205.55
Cipla 1396.35
Zydus Lifesciences 957.25
Lupin 1635.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.